<DOC>
	<DOCNO>NCT03066700</DOCNO>
	<brief_summary>This retrospective study identify prognostic factor good outcome patient present upper GI bleeding tumor receive Hemospray via endoscopy hemostatic control . The good outcome assess immediate hemostasis , rebleeding 72 hour well 7 , 14 30 day follow presentation initial bleeding episode also 6-month survival rate .</brief_summary>
	<brief_title>Prognostic Factors Malignant GI Bleeding Treated With Hemostatic Powder</brief_title>
	<detailed_description>Tumor-related gastrointestinal ( GI ) bleed increase due advancement treatment oncology . However , conventional endoscopic hemostatic method reliable control bleeding . Surgery , embolization , radiotherapy serve salvage hemostasis ; though , bridge endoscopic therapy require resuscitation stabilization patient . Hemospray recent novel endoscopic hemostatis powder trend effective instrument control active upper GI tumor bleed match-pair , case-control study author 's recent publication . Consequently , author hypothesize prognostic factor related outcome Hemospray treatment tumor bleeding .</detailed_description>
	<mesh_term>Hemostatics</mesh_term>
	<criteria>All patient see emergency room and/or hospitalize malignant gastrointestinal haemorrhage 2011 2017 Age &lt; 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>